Does ADC Stratification Within PI-RADS Influence the Benefit of Random Biopsy? Insights From a Middle Eastern MR/US Fusion Biopsy Cohort

Abstract Purpose: Multiparametric magnetic resonance imaging and PIRADS scores transformed prostate cancer diagnostics by enabling targeted biopsy. Within each PI-RADS category, apparent diffusion coefficient (ADC) values vary considerably. We hypothesized that ADC thresholds could serve as an additional predictor to identify patients likely to benefit from the addition of random biopsies to MRI-targeted sampling. Methods Trans-perineal biopsy database of MRI targeted biopsies and systematic biopsies yielded 306 biopsy sessions. ADC values, PI-RADS score, and pathological results were obtained. Lesions were stratified by PI-RADS category (3–5) and ADC threshold (<750 vs ≥750×10⁻⁶ mm²/s). Detection rates between targeted and Systematic biopsies were compared using McNemar tests. Results: Among 306 men, cancer was detected by targeted biopsy alone in 163 cases (53.2%) and by Systematic biopsy in 175 cases (57.2%) (p=0.001). When stratified based on PIRADS score, the benefit of adding random biopsy was shown in PIRADS 4 lesions, with an increased detection by 5.7% (p = 0.004). No statistically significant difference was observed in PIRADS 3 or 5 lesions (p=0.5 and 1.000). Within PIRADS 4 lesions, there was a 6.7% increase in cancer detection in high ADC (≥ 750) lesions (TB: 38.84% vs SB: 45.45%) (p=0.016). However, in low ADC (<750) lesions, SB did not significantly contribute to prostate cancer detection (TB: 73.0% vs SB: 75.68%) (p=1.000) Conclusion: ADC values above 750×10⁻⁶mm²/s identified PI-RADS 4 patients benefit from random biopsies. Overall, random biopsy cores remain valuable in PI-RADS 4 lesions, and ADC stratification could guide biopsy decisions in selected patients.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11540661/v1
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Does ADC Stratification Within PI-RADS Influence the Benefit of Random Biopsy? Insights From a Middle Eastern MR/US Fusion Biopsy Cohort

Oussama G. Nasrallah, Ricardo F. Bitar, Rami Wajih Nasr, Maher Abdessater et al.
6 links
Research Square
Prostate Cancer Diagnosis and Treatment
preprint

Does ADC Stratification Within PI-RADS Influence the Benefit of Random Biopsy? Insights From a Middle Eastern MR/US Fusion Biopsy Cohort

Oussama G. Nasrallah, Ricardo F. Bitar, Rami Wajih Nasr, Maher Abdessater, Raja Bahjat Khauli, Riad A. Khouzami, Bassel G. Bachir, Muhammad Ahmad Bulbul, Albert El Hajj, Ramy Touma Sawaya, Hicham A. Moukaddam, Wissam Osseily, Wassim Wazzan, Dany Eid, Mohammad Fawaz
preprint en

Abstract

Abstract Purpose: Multiparametric magnetic resonance imaging and PIRADS scores transformed prostate cancer diagnostics by enabling targeted biopsy. Within each PI-RADS category, apparent diffusion coefficient (ADC) values vary considerably. We hypothesized that ADC thresholds could serve as an additional predictor to identify patients likely to benefit from the addition of random biopsies to MRI-targeted sampling. Methods Trans-perineal biopsy database of MRI targeted biopsies and systematic biopsies yielded 306 biopsy sessions. ADC values, PI-RADS score, and pathological results were obtained. Lesions were stratified by PI-RADS category (3–5) and ADC threshold (<750 vs ≥750×10⁻⁶ mm²/s). Detection rates between targeted and Systematic biopsies were compared using McNemar tests. Results: Among 306 men, cancer was detected by targeted biopsy alone in 163 cases (53.2%) and by Systematic biopsy in 175 cases (57.2%) (p=0.001). When stratified based on PIRADS score, the benefit of adding random biopsy was shown in PIRADS 4 lesions, with an increased detection by 5.7% (p = 0.004). No statistically significant difference was observed in PIRADS 3 or 5 lesions (p=0.5 and 1.000). Within PIRADS 4 lesions, there was a 6.7% increase in cancer detection in high ADC (≥ 750) lesions (TB: 38.84% vs SB: 45.45%) (p=0.016). However, in low ADC (<750) lesions, SB did not significantly contribute to prostate cancer detection (TB: 73.0% vs SB: 75.68%) (p=1.000) Conclusion: ADC values above 750×10⁻⁶mm²/s identified PI-RADS 4 patients benefit from random biopsies. Overall, random biopsy cores remain valuable in PI-RADS 4 lesions, and ADC stratification could guide biopsy decisions in selected patients.

Research Square
American University of Beirut Medical Center (LB), American University of Beirut (LB)
Good health and well-being
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon